載入...
Everolimus in patients with severe pulmonary hypertension: a safety and efficacy pilot trial
Abstract. Despite the availability of vasodilating compounds, pulmonary hypertension (PH) of various origins remains a disease with a poor prognosis. In recent years, pulmonary arterial hypertension (PAH) has been recognized as a predominantly proliferative process. Everolimus, an inhibitor of the m...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
University of Chicago Press
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4070806/ https://ncbi.nlm.nih.gov/pubmed/24618547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/674311 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|